Paper23136552
IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.
Rose-John S. Int J Biol Sci, 2012. Cited by 855 papers, by iCite.
Cite this record
ConductScience Library. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Papers, record 23136552. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23136552
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cytokine Receptor gp130 | Major topic |
| Interleukin-6 | Major topic |
| Models, Biological | Major topic |
| Receptors, Interleukin-6 | Major topic |
| Animals | |
| Humans | |
| Mice | |
| Mice, Transgenic | |
| Signal Transduction | |
| Solubility |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT02963480 | Investigation of Inflammatory Parameters in a Perioperative Closed-meshed Standard Progress in CPB Patients | Background |
Source ClinicalTrials.gov
References104
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 12960349 | Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130. | J Immunol | 2003 | https://conductscience.org/library/papers/12960349 | PubMed |
| 2 | 16648838 | Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. | Nature | 2006 | https://conductscience.org/library/papers/16648838 | PubMed |
| 3 | 21881215 | Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. | J Clin Invest | 2011 | https://conductscience.org/library/papers/21881215 | PubMed |
| 4 | 17496315 | Local blockade of IL-6R signaling induces lung CD4+ T cell apoptosis in a murine model of asthma via regulatory T cells. | Int Immunol | 2007 | https://conductscience.org/library/papers/17496315 | PubMed |
| 5 | 12633863 | The human interleukin-6 (IL-6) receptor exists as a preformed dimer in the plasma membrane. | FEBS Lett | 2003 | https://conductscience.org/library/papers/12633863 | PubMed |
| 6 | 19109195 | Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis. | J Immunol | 2009 | https://conductscience.org/library/papers/19109195 | PubMed |
| 7 | 8436181 | The soluble interleukin-6 receptor is generated by shedding. | Eur J Immunol | 1993 | https://conductscience.org/library/papers/8436181 | PubMed |
| 8 | 11121117 | Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. | Eur J Biochem | 2001 | https://conductscience.org/library/papers/11121117 | PubMed |
| 9 | 16707558 | Interleukin-6 biology is coordinated by membrane-bound and soluble receptors: role in inflammation and cancer. | J Leukoc Biol | 2006 | https://conductscience.org/library/papers/16707558 | PubMed |
| 10 | 2783334 | The complex pattern of cytokines in serum from patients with meningococcal septic shock. Association between interleukin 6, interleukin 1, and fatal outcome. | J Exp Med | 1989 | https://conductscience.org/library/papers/2783334 | PubMed |
| 11 | 21296109 | The pro- and anti-inflammatory properties of the cytokine interleukin-6. | Biochim Biophys Acta | 2011 | https://conductscience.org/library/papers/21296109 | PubMed |
| 12 | 8751912 | Novel pathogenic mechanism of microbial metalloproteinases: liberation of membrane-anchored molecules in biologically active form exemplified by studies with the human interleukin-6 receptor. | Infect Immun | 1996 | https://conductscience.org/library/papers/8751912 | PubMed |
| 13 | 16912301 | Abrogation of viral interleukin-6 (vIL-6)-induced signaling by intracellular retention and neutralization of vIL-6 with an anti-vIL-6 single-chain antibody selected by phage display. | J Virol | 2006 | https://conductscience.org/library/papers/16912301 | PubMed |
| 14 | 15485627 | TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. | Immunity | 2004 | https://conductscience.org/library/papers/15485627 | PubMed |
| 15 | 16682432 | STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice. | Gut | 2006 | https://conductscience.org/library/papers/16682432 | PubMed |
| 16 | 20083667 | Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells. | J Immunol | 2010 | https://conductscience.org/library/papers/20083667 | PubMed |
| 17 | 18453602 | IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens. | J Immunol | 2008 | https://conductscience.org/library/papers/18453602 | PubMed |
| 18 | 8755571 | Pore-forming toxins trigger shedding of receptors for interleukin 6 and lipopolysaccharide. | Proc Natl Acad Sci U S A | 1996 | https://conductscience.org/library/papers/8755571 | PubMed |
| 19 | 19185844 | gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. | Cancer Cell | 2009 | https://conductscience.org/library/papers/19185844 | PubMed |
| 20 | 8353278 | Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. | Blood | 1993 | https://conductscience.org/library/papers/8353278 | PubMed |
Cited by594
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 855 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42940047 | The Mitophagy Vortex: Bridging Inflammatory, Oxidative, Hypoxic, and Aging Insults to Drive COPD Skeletal Muscle Dysfunction. | Biomedicines | 2026 | https://conductscience.org/library/papers/42940047 | PubMed |
| 42930548 | Interleukin-Driven Inflammation and Cardiovascular Risk in People Living with HIV: Mechanisms, Biomarkers, and Emerging Preventive Strategies. | Med Sci (Basel) | 2026 | https://conductscience.org/library/papers/42930548 | PubMed |
| 42902348 | Blocking IL-6 trans-signaling mitigates benzalkonium chloride-induced inflammation, oxidative imbalance, ER stress, and barrier disruption in human corneal epithelial cells. | Eye Vis (Lond) | 2026 | https://conductscience.org/library/papers/42902348 | PubMed |
| 42897323 | Meprin β is specifically inhibited by its cognate synthetic propeptide. | Cell Mol Life Sci | 2026 | https://conductscience.org/library/papers/42897323 | PubMed |
| 42892641 | IL-1β/IL-6 inflammatory crosstalk drives DNA methylation and histone remodeling associated with cytokine induced senescence in luminal breast cancer. | Inflamm Res | 2026 | https://conductscience.org/library/papers/42892641 | PubMed |
| 42840991 | From IL-6 production to IL-6R buffering: a unified IL-6-IL-6R framework for immune homeostasis during viral infection. | Front Immunol | 2026 | https://conductscience.org/library/papers/42840991 | PubMed |
| 42805593 | Lipotoxicity Amplifies IL-6 Trans-Signaling in Sinusoidal Endothelial Cells to Promote Endotheliopathy and Liver Injury. | J Gastroenterol Hepatol | 2026 | https://conductscience.org/library/papers/42805593 | PubMed |
| 42769565 | Failed resolution as a mechanistic basis of difficult-to-treat rheumatoid arthritis: stromal-myeloid crosstalk in the synovium and emerging resolution-restoring therapies. | Front Immunol | 2026 | https://conductscience.org/library/papers/42769565 | PubMed |
| 42769245 | Changes in circulating immune cells and cytokines after high-intensity aerobic exercise in patients with prostate cancer undergoing active surveillance from the ERASE randomized controlled trial. | Front Immunol | 2026 | https://conductscience.org/library/papers/42769245 | PubMed |
| 42737564 | Interleukin-6 as an Oral-Vascular Inflammatory Bridge: Integrating CXCL10 and Haptoglobin 2-2 into a Potential Model of Periodontitis-Associated Cardiovascular Risk. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42737564 | PubMed |
| 42724928 | The inflammation-immunosuppression loop as a driver of immune dysfunction and secondary infections in severe COVID-19. | Front Immunol | 2026 | https://conductscience.org/library/papers/42724928 | PubMed |
| 42687879 | Uterine factor infertility-current understanding and limitations. | Uterine Res | 2026 | https://conductscience.org/library/papers/42687879 | PubMed |
| 42670519 | Inflammatory and Immune Pathways Driving Tumor Necrosis Factor Inhibitor Resistance in Ulcerative Colitis. | J Inflamm Res | 2026 | https://conductscience.org/library/papers/42670519 | PubMed |
| 42662469 | A proposed convergent molecular chain linking senescence, cancer, and chronic infection to a correctable failure of dendritic cell instruction. | Front Immunol | 2026 | https://conductscience.org/library/papers/42662469 | PubMed |
| 42639359 | Interleukin-6 in complications of prematurity: from biomarker to targeted therapy. | Front Pediatr | 2026 | https://conductscience.org/library/papers/42639359 | PubMed |
| 42631138 | Effect of adding biologic agents to disease-modifying anti-rheumatic drugs for refractory chronic suppurative otitis media: comparative outcomes and cytokine-driven mechanisms. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42631138 | PubMed |
| 42627929 | NF1 Leucine Rich Domain-Derived Extracellular Vesicles Remodel the Glioblastoma Immune Microenvironment via an ADAM17-Associated Inflammatory Program. | J Extracell Vesicles | 2026 | https://conductscience.org/library/papers/42627929 | PubMed |
| 42619373 | Exerkines in precision management of metabolic diseases. | Chin Med J (Engl) | 2026 | https://conductscience.org/library/papers/42619373 | PubMed |
| 42613859 | Hypothalamus-Peripheral Organ Crosstalk in Energy Metabolism: A Bidirectional Regulatory Network. | Endocrinol Metab (Seoul) | 2026 | https://conductscience.org/library/papers/42613859 | PubMed |
| 42579216 | Quantum and nanoscale sensing of microinflammation for earlier detection of chronic inflammatory and neuroimmune disease. | Discov Nano | 2026 | https://conductscience.org/library/papers/42579216 | PubMed |
Genes17
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23136552
GET https://conductscience.org/api/papers/v1/23136552/references?page=2